# SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

> **NCT06794086** · PHASE3 · RECRUITING · sponsor: **Jun Huang** · enrollment: 24 (estimated)

## Conditions studied

- Colorectal Cancer
- Liver Metastases

## Interventions

- **RADIATION:** Stereotactic body radiation therapy
- **DRUG:** PD-1 Monoclonal Antibody
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06794086
- **Lead sponsor:** Jun Huang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-10
- **Primary completion:** 2026-01-20
- **Final completion:** 2027-01-20
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06794086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06794086, "SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06794086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*